Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, View ORCID ProfileMcKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, View ORCID ProfileDenis Nash
doi: https://doi.org/10.1101/2022.04.23.22274214
Saba A Qasmieh
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
McKaylee M Robertson
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Chloe A Teasdale
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Sarah G Kulkarni
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
Denis Nash
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 27, 2022.
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
medRxiv 2022.04.23.22274214; doi: https://doi.org/10.1101/2022.04.23.22274214
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
medRxiv 2022.04.23.22274214; doi: https://doi.org/10.1101/2022.04.23.22274214
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)